1
Agenda
Financial Review
Operation Highlights
Q&A
3
FINANCIAL REVIEW
4
Year 2025.1Q Condensed Consolidated Income Statement
Condensed Consolidated P&L (In Million NTD, except for EPS in NTD) | 2025.1Q % | 2024.4Q % | QoQ % | 2024.1Q % | YoY % | |
Net Sales | 6,865 | 100% | 6,039 100% | 14% | 4,418 100% | 55% |
Consolidated Sales of Testing Equipment Business | 6,456 | 94% | 5,755 95% | 12% | 4,259 96% | 52% |
Consolidated Sales of MAS | 349 | 5% | 211 4% | 65% | 86 2% | 306% |
Others | 60 | 1% | 73 1% | (18%) | 73 2% | (18%) |
Cost of Goods Sold | (2,717) | (40%) | (2,432) (40%) | 12% | (1,852) (42%) | 47% |
Gross Profit | 4,148 | 60% | 3,607 60% | 15% | 2,566 58% | 62% |
Operating Expenses: | ||||||
General & Administration | (1,378) | (20%) | (1,364) (23%) | 1% | (1,181) (27%) | 17% |
Research & Development | (606) | (9%) | (684) (11%) | (11%) | (485) (11%) | 25% |
Operating Income | 2,164 | 31% | 1,559 26% | 39% | 900 20% | 140% |
Non-Operating Income (Expenses), net | 433 | 6% | 380 6% | 14% | 319 7% | 36% |
Income (Loss) Before Tax | 2,597 | 37% | 1,939 32% | 34% | 1,219 27% | 113% |
Income Tax | (441) | (6%) | (403) (7%) | 9% | (243) (5%) | 81% |
Net Income | 2,156 | 31% | 1,536 25% | 40% | 976 22% | 121% |
Net Income (Losses) Attributable To: | ||||||
Shareholders of the Parent | 2,123 | 31% | 1,476 24% | 44% | 955 22% | 122% |
Noncontrolling Interests | 33 | - | 60 1% | (45%) | 21 - | 57% |
$ 2,156 | 31% | $ 1,536 25% | 40% | $ 976 22% | 121% | |
EPS (Basic) | $ 5.03 | $ 3.49 | 44% | $ 2.27 | 122% | |
EPS (Diluted) | $ 4.98 | $ 3.45 | 44% | $ 2.25 | 121% | |
5
Balance Sheet Highlights & Financial Ratio
Consolidated (In Million NTD)
2025. March 2024. Dec + / - %
Balance Sheet Highlights | |||||||
Cash & Short Term Investments | 6,051 | 5,040 | 20% | ||||
Inventory | 5,702 | 5,458 | 4% | ||||
Short Term Debt | 101 | 1,417 | - 93% | ||||
Long Term Debt | 2,339 | 2,108 | 11% | ||||
Shareholders Equity | 24,115 | 25,450 | - 5% | ||||
Total Assets | 38,724 | 37,308 | 4% | ||||
Inventory Turnover (Day) | 185 | 209 | |||||
AR Turnover (Day) | 76 | 87 | |||||
AP Turnover (Day) | 105 | 118 | |||||
Net Debt to Equity (%) | Net Cash | Net Cash | |||||
ROE (%) | 34% | 22% | |||||
ROA (%) | 22% | 15% | |||||
Cash Position | 2025.1Q | 2024.1Q | YoY | ||||
EBITDA | 2,810 | 1,420 | 98% | ||||
Cash Flow from Operation | 1,956 | 1,213 | 61% | ||||
Free Cash Flow | 1,968 | 804 | 145% | ||||
Free Cash Flow = Net Cash Provided by Operating Activities + (Net Cash used by Investing Activities)
6
OPERATION HIGHLIGHT7
2025.1Q Product Mix and Consolidated Sales Breakdown
(Unit: Million NTD) | 2025.1Q | % | QoQ | YoY | 2024 | % |
Test Instruments & Automatic Testing System (ATS) | 2,205 | 42% | 31% | 32% | 6,825 | 44% |
Semiconductor / Photonics Test Solutions | 2,602 | 50% | 25% | 118% | 6,974 | 45% |
Turnkey Solutions | 150 | 3% | 3% | (45%) | 685 | 4% |
Service & Others | 282 | 5% | 3% | 11% | 1,168 | 7% |
Total of Parent Company Sales | 5,239 | 100% | 25% | 54% | 15,652 | 100% |
+ Sales from Overseas Operations & Related Subsidiaries | 1,217 | (22%) | 41% | 4,767 | ||
Chroma Consolidated Testing Equipment Business | 6,456 | 94% | 12% | 52% | 20,419 | 95% |
MAS | 349 | 5% | 65% | 306% | 872 | 4% |
Other Subsidiaries | 60 | 1% | (18%) | (18%) | 313 | 1% |
Consolidated Sales | 6,865 | 100% | 14% | 55% | 21,604 | 97% |
8
Thank You
Copyright © 2023 Chroma ATE Inc. All rights reserved9.
| Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |